Kevin P Vincent1, Nickolas Forsch1, Sachin Govil1, Jake M Joblon2, Jeffrey H Omens1,2, James C Perry3,4, Andrew D McCulloch1,2. 1. Department of Bioengineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0412, USA. 2. Department of Medicine, University of California San Diego, La Jolla, CA, USA. 3. Department of Pediatrics, University of California San Diego, La Jolla, CA, USA. 4. Rady Children's Hospital, San Diego, CA, USA.
Abstract
AIMS: Ventricular activation patterns can aid clinical decision-making directly by providing spatial information on cardiac electrical activation or indirectly through derived clinical indices. The aim of this work was to derive an atlas of the major modes of variation of ventricular activation from model-predicted 3D bi-ventricular activation time distributions and to relate these modes to corresponding vectorcardiograms (VCGs). We investigated how the resulting dimensionality reduction can improve and accelerate the estimation of activation patterns from surface electrogram measurements. METHODS AND RESULTS: Atlases of activation time (AT) and VCGs were derived using principal component analysis on a dataset of simulated electrophysiology simulations computed on eight patient-specific bi-ventricular geometries. The atlases provided significant dimensionality reduction, and the modes of variation in the two atlases described similar features. Utility of the atlases was assessed by resolving clinical waveforms against them and the VCG atlas was able to accurately reconstruct the patient VCGs with fewer than 10 modes. A sensitivity analysis between the two atlases was performed by calculating a compact Jacobian. Finally, VCGs generated by varying AT atlas modes were compared with clinical VCGs to estimate patient-specific activation maps, and the resulting errors between the clinical and atlas-based VCGs were less than those from more computationally expensive method. CONCLUSION: Atlases of activation and VCGs represent a new method of identifying and relating the features of these high-dimensional signals that capture the major sources of variation between patients and may aid in identifying novel clinical indices of arrhythmia risk or therapeutic outcome. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Ventricular activation patterns can aid clinical decision-making directly by providing spatial information on cardiac electrical activation or indirectly through derived clinical indices. The aim of this work was to derive an atlas of the major modes of variation of ventricular activation from model-predicted 3D bi-ventricular activation time distributions and to relate these modes to corresponding vectorcardiograms (VCGs). We investigated how the resulting dimensionality reduction can improve and accelerate the estimation of activation patterns from surface electrogram measurements. METHODS AND RESULTS: Atlases of activation time (AT) and VCGs were derived using principal component analysis on a dataset of simulated electrophysiology simulations computed on eight patient-specific bi-ventricular geometries. The atlases provided significant dimensionality reduction, and the modes of variation in the two atlases described similar features. Utility of the atlases was assessed by resolving clinical waveforms against them and the VCG atlas was able to accurately reconstruct the patient VCGs with fewer than 10 modes. A sensitivity analysis between the two atlases was performed by calculating a compact Jacobian. Finally, VCGs generated by varying AT atlas modes were compared with clinical VCGs to estimate patient-specific activation maps, and the resulting errors between the clinical and atlas-based VCGs were less than those from more computationally expensive method. CONCLUSION: Atlases of activation and VCGs represent a new method of identifying and relating the features of these high-dimensional signals that capture the major sources of variation between patients and may aid in identifying novel clinical indices of arrhythmia risk or therapeutic outcome. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Nicolas Duchateau; Mathieu De Craene; Gemma Piella; Etelvino Silva; Adelina Doltra; Marta Sitges; Bart H Bijnens; Alejandro F Frangi Journal: Med Image Anal Date: 2011-01-26 Impact factor: 8.545
Authors: Sophie Giffard-Roisin; Herve Delingette; Thomas Jackson; Jessica Webb; Lauren Fovargue; Jack Lee; Christopher A Rinaldi; Reza Razavi; Nicholas Ayache; Maxime Sermesant Journal: IEEE Trans Biomed Eng Date: 2018-05-23 Impact factor: 4.538
Authors: Xingyu Zhang; Brett R Cowan; David A Bluemke; J Paul Finn; Carissa G Fonseca; Alan H Kadish; Daniel C Lee; Joao A C Lima; Avan Suinesiaputra; Alistair A Young; Pau Medrano-Gracia Journal: PLoS One Date: 2014-10-31 Impact factor: 3.240
Authors: Kathleen Gilbert; Wenjia Bai; Charlene Mauger; Pau Medrano-Gracia; Avan Suinesiaputra; Aaron M Lee; Mihir M Sanghvi; Nay Aung; Stefan K Piechnik; Stefan Neubauer; Steffen E Petersen; Daniel Rueckert; Alistair A Young Journal: Sci Rep Date: 2019-02-04 Impact factor: 4.379
Authors: Kevin P Vincent; Matthew J Gonzales; Andrew K Gillette; Christopher T Villongco; Simone Pezzuto; Jeffrey H Omens; Michael J Holst; Andrew D McCulloch Journal: Front Physiol Date: 2015-08-05 Impact factor: 4.566